Trading Halt Request
Released
Released
Announcement PDF
Monday 7 March 2016
Kate Kidson
Principal Adviser
Listings Compliance (Melbourne)
ASX Compliance Pty Limited
Email: kate.kidson@asx.com.au
Dear Kate,
Request for Trading Halt for Antisense Therapeutics Limited
In accordance with ASX Listing Rule 17.1, the Directors of Antisense Therapeutics Limited (“the
Company”) request an immediate trading halt in respect of its securities (ASX Code: ANP).
In requesting the trading halt, the Company provides the following information:
The trading halt is requested pending an announcement in relation to the ATL1103
program;
Unless otherwise requested by the Company, the Company requests the trading halt to
remain in place until the earlier of the release of an announcement to the market or the
morning of Wednesday 9th March 2016; and
The Company is not aware of any reason why the trading halt should not be granted or of
any other information necessary to inform the market about the trading halt.
Yours sincerely,
Phillip Hains
Company Secretary
6-8 Wallace Avenue
Toorak, Victoria
Australia 3142
Antisense Therapeutics Limited
ABN 41 095 060 745
www.antisense.com.au
Phone:
+ 61 (0)3 9827 8999
Facsimile: + 61 (0)3 9827 1166
Share your feedback
Discover